In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009.

Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA.

A study published in Stem Cells Translational Medicine found that an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele.

John Tierney, DO, used Anika Therapeutics' injectable hyaluronic acid-based bone repair product in a patient.

Bioventus plans to expand Durolane, its hyaluronic acid joint-fluid osteoarthritis injection, into Australia and New Zealand.

Daniel Penello, MD, of Alexander Orthopaedic Associates in St. Petersburg, Fla., is a fellowship-trained orthopedic surgeon who specializes in hand and upper extremity surgery.

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate.

PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports.

The California Institute for Regenerative Medicine has been instrumental in stem cell research since it was first established in 2004, but it faces closure in 2022 if a ballot initiative to get it more funding is unsuccessful. 

Discgenics treated the first patients in its clinical trial of intervertebral disc tissue for mild to moderate degenerative disc disease in Japan, reports Biospectrum Asia.

Andreas Gomoll, MD, implanted Cartiheal's Agili-C in two patients in an investigational device exemption study at Hospital for Special Surgery in New York City.

NanoFuse Biologics is launching its biologic in Panama City, Panama, through a partnership with medical distributor PTY Medical Group.

Camber Spine is widening its portfolio by tapping into the biologics market.

Biologics development company AgeX Therapeutics added Michael May, PhD, to its board of directors, returning it to full strength.

Chad Kurtenbach, MD, of Sioux Falls, S.D.-based Sanford Health is conducting a study of a stem cell treatment for patients with osteoarthritis in the knee.

Biologics has the potential to be the next transformative tool in the orthopedic surgeon's playbook, but the field still has a ways to go before it becomes a mainstream medicinal offering.

Health plan provider Gilsbar entered into a partnership with interventional orthopedic clinic network Regenexx to provide beneficiaries access to reduced-cost musculoskeletal care options.

The California Institute for Regenerative Medicine was never supposed to last infinitely, but a new ballot initiative could extend its lifespan, Nature reports.

NanoFuse released NanoStrip, a glass synthetic biologic strip clinicians can use in spine and orthopedic procedures.

The FDA approved Personalized Stem Cells' new drug application for its adipose-derived stem cell-based osteoarthritis treatment.